The Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select ETF seeks to replicate as closely as possible the price and yield performance of the Hang Seng SCHK Innovative Drug Select Index by investing in a portfolio comprised primarily of Chinese pharmaceutical companies
The Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The Hwabao WP Fund Management fund’s base currency is CNY and the share class was registered 27.06.2025 with unique ISIN - CNE100006XY4. Main exchange is Shanghai SE and ticker symbol is 520880. The total expense ratio is 0.6%. The Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select ETF (CNY) pays dividends 1 time(s) per year.